What is the treatment for Tinea (ringworm)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea (Ringworm)

For tinea corporis and tinea cruris, topical terbinafine 1% cream applied once daily for 1 week is the first-line treatment, while tinea capitis requires oral antifungal therapy with agent selection based on the causative organism. 1, 2

Tinea Corporis and Tinea Cruris (Body and Groin)

First-Line Topical Treatment

  • Terbinafine 1% cream once daily for 1 week is the preferred first-line treatment for localized tinea corporis and tinea cruris, offering the shortest treatment duration with high efficacy 1, 2, 3
  • This regimen is FDA-approved for children 12 years and older 2

Alternative Topical Options

  • Butenafine twice daily for 2 weeks is an effective over-the-counter alternative if terbinafine is unavailable or not tolerated 1, 2
  • Clotrimazole 1% twice daily for 4 weeks provides another alternative, though requiring longer treatment duration 1, 2
  • Standard azole treatment duration is 2 weeks, compared to only 1 week with terbinafine 1

When to Use Oral Therapy

  • Reserve oral antifungals for extensive infections, treatment failures, or immunocompromised patients 1
  • Oral options include fluconazole 50-100 mg daily or 150 mg weekly for 2-3 weeks, itraconazole 100 mg daily for 2 weeks, or terbinafine 250 mg daily for 1-2 weeks 4

Treatment Endpoint and Follow-Up

  • Mycological cure, not just clinical improvement, is the definitive treatment endpoint 1
  • Continue treatment for at least 1 week after clinical clearing to prevent relapse 1
  • If clinical improvement occurs but mycology remains positive, continue current therapy for an additional 2-4 weeks 1, 2

Tinea Capitis (Scalp Ringworm)

Critical Treatment Principle

  • Oral antifungal therapy is mandatory for tinea capitis; topical therapy alone is ineffective and should never be used as monotherapy 5

Organism-Directed First-Line Therapy

  • For Trichophyton species: Terbinafine is the preferred agent due to its fungicidal activity and superior efficacy 5

    • Weight-based dosing: 62.5 mg/day for <20 kg, 125 mg/day for 20-40 kg, 250 mg/day for >40 kg 5
    • Treatment duration: 2-4 weeks 5
    • Advantages include shorter treatment duration (improving compliance) with gastrointestinal disturbances and rashes occurring in less than 8% of children 5
  • For Microsporum species: Griseofulvin is the preferred agent 5

    • Dosing: 15-20 mg/kg/day (or 10 mg/kg/day per FDA label) for children under 50 kg; 1 g/day for children over 50 kg and adults 5, 6
    • Treatment duration: 6-8 weeks 5, 6
    • Terbinafine fails against Microsporum because it cannot be incorporated into hair shafts in prepubertal children and doesn't reach the scalp surface where arthroconidia are located 5

When to Start Treatment Empirically

  • Start treatment before mycology results if cardinal clinical signs are present: scale, lymphadenopathy, alopecia, or kerion 5
  • Collect specimens via scalp scrapings, hair pluck, brush, or swab for microscopy and culture 5

Second-Line Options for Treatment Failure

  • Consider factors such as poor compliance, suboptimal drug absorption, organism insensitivity, or reinfection if initial therapy fails 5
  • Itraconazole 5 mg/kg/day for 2-4 weeks is effective against both Trichophyton and Microsporum species 5
  • Fluconazole is an alternative for refractory cases with favorable tolerability and liquid formulation availability 5

Adjunctive Measures

  • Use topical antifungal therapy as adjunctive treatment only 5
  • Screen and treat all family members and close contacts, especially for T. tonsurans infections 5
  • Cleanse hairbrushes and combs with bleach or 2% sodium hypochlorite solution 5
  • Children receiving appropriate systemic and adjunctive topical therapy can attend school or nursery; exclusion is impractical and unnecessary 5

Tinea Pedis (Athlete's Foot)

Treatment Duration

  • Topical azoles for 4 weeks or allylamines for 1-2 weeks 7, 4
  • Oral therapy may be required for extensive or chronic cases: itraconazole 100 mg daily for 2 weeks or 400 mg daily for 1 week, terbinafine 250 mg daily for 2 weeks, or fluconazole 150 mg weekly 4

Prevention Strategies

For Tinea Cruris

  • Cover active tinea pedis with socks before wearing undershorts to reduce direct contamination 1, 2
  • Completely dry the groin folds after bathing 1, 2
  • Use separate towels for drying the groin and other body parts 1, 2
  • Avoid skin-to-skin contact with infected individuals and sharing of personal items 1

General Hygiene Measures

  • Practice good personal hygiene and keep skin dry and cool 8
  • Avoid sharing towels, clothing, or hair accessories with infected individuals 8
  • Clean contaminated clothing and personal items 1

Common Pitfalls to Avoid

  • Never use topical therapy alone for tinea capitis - it cannot eradicate scalp infections 5
  • Never use terbinafine for Microsporum infections due to poor efficacy 5
  • Avoid underdosing griseofulvin, as higher doses are needed due to increasing treatment failures with lower doses 5
  • Treatment failure may result from poor compliance, suboptimal absorption, organism insensitivity, or reinfection 2
  • Griseofulvin is contraindicated in lupus erythematosus, porphyria, and severe liver disease 1

References

Guideline

Tinea Cruris Diagnosis and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Topical Treatment of Tinea Cruris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Guideline

Treatment of Tinea Capitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.